Literature DB >> 26946221

24-Hour infusion of levodopa/carbidopa intestinal gel for nocturnal akinesia in advanced Parkinson's disease.

Lucia Ricciardi1, Francesco Bove2, Kristy J Espay3, Francesco Lena4, Nicola Modugno4, Yu-Yan Poon5, Robert Krikorian6, Alberto J Espay3, Alfonso Fasano5.   

Abstract

Entities:  

Keywords:  Parkinson's disease; intrajejunal levodopa; nonmotor symptoms; sleep

Mesh：

Substances：

Year:  2016        PMID： 26946221     DOI： 10.1002/mds.26564

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  9 in total

1.  Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson's Disease.

Authors:  Eva Schaeffer; Thomas Vaterrodt; Laura Zaunbrecher; Inga Liepelt-Scarfone; Kirsten Emmert; Benjamin Roeben; Morad Elshehabi; Clint Hansen; Sara Becker; Susanne Nussbaum; Jan-Hinrich Busch; Matthis Synofzik; Daniela Berg; Walter Maetzler
Journal:  J Neurol       Date:  2021-02-05       Impact factor: 4.849

Review 2.  Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?

Authors:  Maria José Catalán; Angelo Antonini; Matilde Calopa; Ovidiu Băjenaru; Oriol de Fábregues; Adolfo Mínguez-Castellanos; Per Odin; José Manuel García-Moreno; Stephen W Pedersen; Zvezdan Pirtošek; Jaime Kulisevsky
Journal:  eNeurologicalSci       Date:  2017-07-02

3.  Acute levodopa dosing around-the-clock ameliorates REM sleep without atonia in hemiparkinsonian rats.

Authors:  Vishakh Iyer; Quynh Vo; Anthony Mell; Siven Chinniah; Ashley Zenerovitz; Kala Venkiteswaran; Allen R Kunselman; Jidong Fang; Thyagarajan Subramanian
Journal:  NPJ Parkinsons Dis       Date:  2019-11-29

Review 4.  24-Hour Levodopa-Carbidopa Intestinal Gel: Clinical Experience and Practical Recommendations.

Authors:  Sandeep Thakkar; Victor S C Fung; Aristide Merola; Meredith Rollins; Michael J Soileau; Norbert Kovács
Journal:  CNS Drugs       Date:  2021-02-13       Impact factor: 5.749

Review 5.  Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The COVID-19 Experience.

Authors:  Alfonso Fasano; Angelo Antonini; Regina Katzenschlager; Paul Krack; Per Odin; Andrew H Evans; Thomas Foltynie; Jens Volkmann; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2020-05-04

Review 6.  Implementing Levodopa-Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners.

Authors:  Michelle Burack; Jason Aldred; Cindy Zadikoff; Arvydas Vanagunas; Kevin Klos; Bahri Bilir; Hubert H Fernandez; David G Standaert
Journal:  Mov Disord Clin Pract       Date:  2018-06-27

7.  24-hour levodopa-carbidopa intestinal gel may reduce troublesome dyskinesia in advanced Parkinson's disease.

Authors:  Belinda Cruse; Hugo Morales-Briceño; Florence C F Chang; Neil Mahant; Ainhi D Ha; Samuel D Kim; Nigel Wolfe; Vu Kwan; David S Tsui; Jane M Griffith; Donna Galea; Victor S C Fung
Journal:  NPJ Parkinsons Dis       Date:  2018-11-20

Review 8.  The Choice Between Advanced Therapies for Parkinson's Disease Patients: Why, What, and When?

Authors:  Joke M Dijk; Alberto J Espay; Regina Katzenschlager; Rob M A de Bie
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

9.  Management Challenges of Severe, Complex Dyskinesia. Data from a Large Cohort of Patients Treated with Levodopa-Carbidopa Intestinal Gel for Advanced Parkinson's Disease.

Authors:  József Attila Szász; Viorelia Adelina Constantin; Károly Orbán-Kis; Ligia Ariana Bancu; Marius Ciorba; István Mihály; Előd Ernő Nagy; Róbert Máté Szász; Krisztina Kelemen; Mihaela Adriana Simu; Szabolcs Szatmári
Journal:  Brain Sci       Date:  2021-06-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.